Emmanuelle V. LeBlanc

发表

Fungal-Selective Resorcylate Aminopyrazole Hsp90 Inhibitors: Optimization of Whole-Cell Anticryptococcal Activity and Insights into the Structural Origins of Cryptococcal Selectivity.

L. Cowen, D. Krysan, G. Privé, 2021, Journal of medicinal chemistry.

SARS-CoV-2 RNA: Exclusive friends and common foes

Che C. Colpitts, Emmanuelle V. LeBlanc, 2021, Cell.

Hepatitis C Virus Glycan-Dependent Interactions and the Potential for Novel Preventative Strategies

Youjin Kim, Che C. Colpitts, Chantelle J. Capicciotti, 2021, Pathogens.

The green tea catechin EGCG provides proof-of-concept for a pan-coronavirus attachment inhibitor

Che C. Colpitts, Emmanuelle V. LeBlanc, Emmanuelle V. Leblanc, 2022, Scientific Reports.

A dual antibody test for accurate surveillance of SARS-CoV-2 exposure rates

Che C. Colpitts, Emmanuelle V. LeBlanc, 2021, Cell Reports Medicine.

Activation of TLR4 by viral glycoproteins: A double-edged sword?

K. Gee, Che C. Colpitts, Emmanuelle V. LeBlanc, 2022, Frontiers in Microbiology.

The green tea catechin EGCG provides proof-of-concept for a pan-coronavirus entry inhibitor

Che C. Colpitts, Emmanuelle V. LeBlanc, 2021, bioRxiv.

Design and synthesis of fungal-selective resorcylate aminopyrazole Hsp90 inhibitors.

L. Cowen, D. Krysan, Tanvi Shekhar-Guturja, 2019, Journal of medicinal chemistry.

Structural basis for species-selective targeting of Hsp90 in a pathogenic fungus

S. Lindquist, L. Cowen, D. Krysan, 2019, Nature Communications.

Structure-guided approaches to targeting stress responses in human fungal pathogens

L. Cowen, G. Privé, Elizabeth J. Polvi, 2020, The Journal of Biological Chemistry.

Defining the Yeast Resistome through in vitro Evolution and Whole Genome Sequencing

Jacob D. Durrant, Gregory M. Goldgof, Andrea L. Cheung, 2021, bioRxiv.

Adaptive laboratory evolution in S. cerevisiae highlights role of transcription factors in fungal xenobiotic resistance

Joshua R. Smith, Jacob D. Durrant, Gregory M. Goldgof, 2022, Communications biology.